Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Argus Health
Chubb
Deloitte
UBS
Colorcon
Boehringer Ingelheim
Cipla
Federal Trade Commission
US Department of Justice

Generated: January 19, 2018

DrugPatentWatch Database Preview

MANNITOL 25% Drug Profile

« Back to Dashboard

Drug patent expirations by year for MANNITOL 25%
Pharmacology for MANNITOL 25%
Drug ClassOsmotic Diuretic
Mechanism of ActionOsmotic Activity
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for MANNITOL 25%

US Patents and Regulatory Information for MANNITOL 25%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm MANNITOL 25% mannitol INJECTABLE;INJECTION 086754-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Intl Medication MANNITOL 25% mannitol INJECTABLE;INJECTION 083051-001 Approved Prior to Jan 1, 1982 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira MANNITOL 25% mannitol INJECTABLE;INJECTION 016269-006 Aug 25, 1994 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold MANNITOL 25% mannitol INJECTABLE;INJECTION 087409-001 Jan 21, 1982 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa MANNITOL 25% mannitol INJECTABLE;INJECTION 080677-001 Approved Prior to Jan 1, 1982 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira MANNITOL 25% mannitol INJECTABLE;INJECTION 016269-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Igi Labs Inc MANNITOL 25% mannitol INJECTABLE;INJECTION 089240-001 May 6, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Igi Labs Inc MANNITOL 25% mannitol INJECTABLE;INJECTION 089239-001 May 6, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs MANNITOL 25% mannitol INJECTABLE;INJECTION 087460-001 Jun 27, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck MANNITOL 25% mannitol INJECTABLE;INJECTION 005620-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office
Teva
Daiichi Sankyo
McKinsey
Dow
Citi
Novartis
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot